跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HIF-2 alpha inhibitor (cancer)
首页
药物
HIF-2 alpha inhibitor (cancer)
HIF-2 alpha inhibitor (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS FOR TREATING CANCER OR VON-HIPPEL LINDAU DISEASE USING A COMBINATION OF A HIF-2 ALPHA INHIBITOR AND LENVATINIB
申请人: MERCK SHARP & DOHME LLC
优先权: 2020
CN
EP
US
WO
4 件公开
METHODS FOR TREATING CANCER, OR VON-HIPPEL LINDAU DISEASE USING A COMBINATION OF A TIGIT ANTAGONIST, A PD-1 ANTAGONIST, AND A HIF-2-ALPHA INHIBITOR
申请人: MERCK SHARP & DOHME LLC
优先权: 2023
US
METHODS FOR TREATING CANCER OR VON-HIPPEL LINDAU DISEASE USING A COMBINATION OF A PD-1 ANTAGONIST, A HIF-2 ALPHA INHIBITOR, AND LENVATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
申请人: MERCK SHARP & DOHME LLC
优先权: 2020
EP
US
2 件公开
METHODS FOR TREATING CANCER OR VON-HIPPEL LINDAU DISEASE USING A COMBINATION OF A PD-1 ANTAGONIST, A HIF-2 ALPHA INHIBITOR, AND LENVATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
申请人: MERCK SHARP & DOHME
优先权: 2020
WO
Hypoxia inducible factor-2 (alpha) inhibitors for treatment of bladder cancer
申请人: NICAN THERAPEUTICS AG
优先权: 2021
CN
药物
反馈